BCL2 and cancer: The fate of cells is dictated by the intricate balance of interactions between the different groups of Bcl-2 family proteins, a balance often found to be dysregulated in drug-resistant cancer cells and therefore a sought-after target for pharmacological intervention against cancer [12,13,14,15].